Acetylcysteine

Introduction Overview

Generic Name

acetylcysteine

Brand Name

NAC, N-A-C Sustain, Mucomyst, Acetadote, Acys-5, Cetylev

Dosage Form

oral tablets, oral sustained-release tablets, oral solution, intravenous solution, inhalation solution

Drug Class

mucolytic agent, antioxidant precursor, acetaminophen antidote

Pharmacokinetics

Absorption:
Acetylcysteine (NAC) demonstrates variable and generally low oral bioavailability due to significant first-pass hepatic metabolism. After oral administration, absorption occurs primarily in the small intestine. Peak plasma concentrations are generally attained within 1 to 2 hours. The molecule exhibits rapid uptake but suffers from extensive deacetylation and conjugation in the intestinal mucosa and liver, reducing systemic exposure. Food intake may delay absorption slightly but does not significantly reduce bioavailability.

Distribution:
Once absorbed, NAC distributes widely in body tissues, including the liver, kidneys, lungs, and brain. It crosses cellular membranes via active transport and passive diffusion, enabling replenishment of intracellular glutathione stores. NAC has a relatively low plasma protein binding, approximately 30%, facilitating tissue penetration. It is actively accumulated in cells where it serves as a cysteine donor for glutathione synthesis, the body's major antioxidant. The volume of distribution ranges moderately and reflects the intracellular localization of glutathione synthesis.

Metabolism:
NAC undergoes extensive hepatic metabolism predominantly through deacetylation to yield cysteine, which is subsequently utilized in glutathione synthesis. Additional metabolic pathways include conjugation reactions such as sulfation and glucuronidation. The acetyl group is removed enzymatically, and cysteine formed acts as a precursor for antioxidative molecules. NAC supplementation thus enhances endogenous antioxidant defenses by serving as a rate-limiting substrate in glutathione production. Metabolites are primarily endogenous sulfur-containing compounds rather than distinct xenobiotic metabolites.

Elimination:
The elimination of NAC and its metabolites occurs primarily via the renal route. Within hours after administration, metabolites including cysteine and its derivatives are excreted in urine. The elimination half-life of NAC ranges between 5.6 to 6.25 hours following intravenous administration, but this can vary with dose and patient condition. Renal clearance plays a key role, and impairment of kidney function can prolong elimination. Minimal fecal excretion occurs. Clinical monitoring during therapy accounts for the pharmacokinetic profile to optimize dosing intervals, especially in overdose situations.

Dosage Forms

Available Dosage Forms:
- Oral tablets: typically 600 mg
- Oral sustained-release tablets: examples include 'N-A-C Sustain'
- Oral solution: various concentrations used for oral administration
- Intravenous solution: used primarily in hospital settings for acetaminophen overdose
- Inhalation solution: nebulized form used as mucolytic agent in respiratory disorders

Dosages for Adults and Adolescents:
- Acetaminophen overdose antidote therapy: loading dose of 140 mg/kg orally followed by maintenance doses of 70 mg/kg every 4 hours for 17 additional doses (total 18 doses) as per protocol
- Mucolytic therapy: oral dosing often 600 mg daily, divided in two or three doses, depending on condition
- Other indications and dosing regimens vary, individualized by clinical condition, including respiratory disorders

Specific Patient Populations:
- In patients with renal impairment, dosing adjustments or monitoring may be necessary due to altered elimination
- Pediatric dosing typically adjusted by weight and indication; intravenous dosing protocols exist for overdose
- Pregnant and breastfeeding patients should use NAC only if clearly needed and with medical supervision
- Caution is advised in patients with gastric ulcers, esophageal varices, and heart failure due to potential adverse effects

Clinical Guidelines:
- NAC is administered under strict medical supervision when used as an antidote in acetaminophen toxicity, with protocols involving plasma acetaminophen level determination
- Over-the-counter NAC preparations for supplemental or mucolytic use vary in dose and formulation; effectiveness as antidote depends on form and adherence to clinical dosing schedules

Mechanism Of Action

Acetylcysteine functions primarily as a precursor to the endogenous antioxidant glutathione. It provides cysteine, an essential amino acid substrate for glutathione synthesis within cells. Glutathione serves to maintain redox balance, detoxify reactive oxygen species, and protect cellular components from oxidative damage. This mechanism underpins NAC's protective effects in oxidative stress-related conditions and organ toxicities.

In acetaminophen overdose, NAC replenishes depleted hepatic glutathione stores, enabling detoxification of the reactive acetaminophen metabolite N-acetyl-p-benzoquinone imine (NAPQI). NAPQI is normally conjugated and rendered harmless via glutathione conjugation; in overdose, glutathione depletion leads to hepatocellular injury. Administration of NAC restores glutathione levels, preventing or mitigating liver damage.

Beyond antioxidant restoration, NAC exhibits mucolytic properties by disrupting disulfide bonds in mucoproteins within respiratory secretions. This action decreases mucus viscosity and facilitates expectoration, making NAC useful in respiratory tract disorders characterized by thick secretions.

Research also identifies NAC’s modulation of inflammatory pathways and mitochondrial function. NAC affects nuclear factor-kappa B (NF-κB) and other signal transduction mediators, thereby modulating inflammatory gene expression. Comparative studies highlight NAC's advantage over other antioxidants in directly replenishing intracellular glutathione, offering clinical efficacy in diverse oxidative stress conditions. Ongoing studies investigate its role in neuroprotection, fertility, and chronic respiratory diseases, supporting its multifaceted pharmacodynamics.

Pharmacological Actions

Acts as a precursor to cysteine for glutathione synthesis, replenishing intracellular antioxidant defenses
Detoxifies reactive metabolites in acetaminophen overdose via glutathione-mediated conjugation
Exhibits mucolytic activity by cleaving disulfide bonds in mucoproteins reducing mucus viscosity
Modulates inflammatory pathways including inhibition of NF-κB activation and cytokine release
Reduces oxidative stress in various tissues including liver, lungs, and brain
Protects hepatocytes from acetaminophen and other toxin-induced injury
Promotes cellular redox balance and mitochondrial function
Supports immune system function by enhancing antioxidant capacity
Demonstrates neuroprotective potential through antioxidant and anti-inflammatory effects
Improves respiratory function by facilitating mucus clearance in chronic bronchitis, cystic fibrosis, and COPD
May enhance fertility through reduction of oxidative damage in reproductive tissues
Antidotal effect in acute liver failure associated with acetaminophen toxicity
Acts as a scavenger for free radicals and reactive oxygen species
Supports detoxification pathways in the liver and other organs

Therapeutic Or Clinical Uses

Antidote for acetaminophen (paracetamol) overdose and prevention of resultant acute liver failure
Mucolytic agent in management of respiratory diseases with thick viscous mucus: chronic bronchitis, cystic fibrosis, pneumonia, bronchiectasis, pulmonary emphysema
Supportive treatment in conditions of oxidative stress to replenish glutathione stores
Potential adjunct in chronic obstructive pulmonary disease (COPD) to improve mucus clearance and reduce exacerbations
Investigational use in improving fertility related to oxidative damage in reproductive tract
Investigational and adjunctive therapy in neurological disorders due to antioxidant properties
Supportive therapy in hepatic disorders to protect against oxidative damage
Dietary supplement to enhance antioxidant status in various clinical and subclinical conditions
Mucolytic therapy in acute respiratory infections to facilitate sputum clearance
Adjunct treatment in psychiatric disorders under investigation for brain oxidative stress modulation
Potential chemopreventive agent due to modulation of oxidative damage and inflammation
Use in prevention and treatment of pulmonary fibrosis
Antioxidant supplementation in systemic inflammatory conditions
Reducing contrast-induced nephropathy risk in certain clinical protocols
Use in chronic diseases associated with glutathione depletion and oxidative injury

Side Or Adverse Effects

Nausea and vomiting, often transient and dose-related
Gastrointestinal upset including dyspepsia and abdominal discomfort
Hypersensitivity reactions including rash, urticaria, or pruritus
Anaphylactoid reactions, especially with intravenous administration, including bronchospasm, hypotension, and flushing
Fever and chills
Rare reports of angioedema and swelling of face, lips, tongue, or throat
Coughing or bronchospasm related to inhalation forms
Potential for vomiting within one hour of oral dose necessitating repeat dosing
Allergic reactions requiring immediate medical attention
Headache and dizziness reported occasionally
Potential exacerbation of gastric ulcers or bleeding in susceptible patients
Rare hematologic reactions such as eosinophilia
Localized injection site reactions with intravenous formulations
Possible interactions increasing risk of bleeding when combined with anticoagulants (theoretical)
Rare incidence of signs indicating drug failure or worsening liver function such as jaundice, dark urine, or clay-colored stools during overdose treatment

Precautions

Avoid use in patients with known hypersensitivity to acetylcysteine or formulation excipients
Use cautiously in patients with active peptic ulcers or history of gastrointestinal bleeding due to mucosal irritation risk
Monitor patients with esophageal varices for bleeding risk
Cautious use in patients with congestive heart failure or fluid overload risk due to possible sodium content
Adjust dosing or monitor closely in renal impairment due to altered elimination
Inform healthcare providers if pregnant or breastfeeding before administration
During emergency overdose treatment, ensure proper laboratory monitoring of acetaminophen levels and liver function tests
Avoid self-medication in suspected acetaminophen overdose without medical evaluation
Instruct patients on importance of completing full course especially in antidotal treatment to prevent hepatotoxicity
Be vigilant for signs of anaphylactoid reactions particularly with intravenous use
Use caution when combining with anticoagulants or drugs affecting coagulation
Avoid use in patients on low-salt diets without medical supervision; some formulations contain sodium
Ensure intake instructions are understood; repeat dosing may be necessary if vomiting occurs within one hour
Store drug properly to maintain stability; away from moisture and heat
Regularly assess for adverse effects and therapeutic response during prolonged use

Warnings

Serious allergic reactions including anaphylaxis and bronchospasm can occur, especially with intravenous administration
Do not delay acetaminophen overdose treatment; immediate medical evaluation is critical
Signs of liver failure such as jaundice, dark urine, or clay-colored stools require urgent medical attention and may indicate treatment failure
In emergency situations, patient may not communicate history; caregivers must be informed of NAC administration
Use under medical supervision only; inappropriate use or dosing may result in ineffective treatment or adverse effects
Pregnancy and breastfeeding status must be considered and disclosed if possible before administration
Intravenous NAC should be given cautiously with monitoring of vital signs to detect hypersensitivity
NAC may cause severe vomiting leading to dosing challenges; medical re-evaluation may be needed
Not all over-the-counter formulations are effective for acetaminophen overdose treatment
Avoid use in patients with severe asthma without monitoring due to risk of bronchospasm
Caution is advised when used in patients with bleeding disorders or on anticoagulant therapy
Interaction with other drugs may alter effectiveness or increase adverse effects
Ensure proper dosing intervals to maintain therapeutic plasma levels
Overdose of NAC itself is rare but should be managed with supportive care
Proper storage and handling are necessary to maintain drug efficacy

Contraindication

Known hypersensitivity or allergic reaction to acetylcysteine or formulation components
Use in patients with active gastrointestinal hemorrhage or severe peptic ulcer without medical supervision
Intravenous use contraindicated in patients with uncontrolled bronchospasm
Use cautiously or avoid in patients with severe hypotension or unstable cardiovascular status during administration
Patients with a history of severe anaphylactoid reactions to NAC
Use of non-antidotal NAC formulations in place of medically prescribed overdose therapy
Avoid co-administration with drugs known to cause hypersensitivity to thiol-containing compounds
Contraindicated in individuals who cannot swallow oral dosage forms safely without risk of aspiration
Do not use formulations intended for inhalation systemically
Avoid in patients with known hypersensitivity to any excipients used in specific formulations
Not suitable for self-treatment of acetaminophen overdose without medical guidance
Use contraindicated if patient is unable to undergo appropriate monitoring

Drug Interactions

Potential increased risk of bleeding when combined with anticoagulants or antiplatelet agents
May interact with activated charcoal, which could impair absorption when co-administered orally
Concurrent use with nitroglycerin or other nitrates may enhance vasodilatory effects
Effects on efficacy of chemotherapy agents are under investigation; caution advised
May reduce efficacy of certain immunosuppressive drugs due to antioxidant properties
No significant interactions noted with most common medications but monitoring is recommended
Co-administration with cough suppressants could reduce expectoration efficacy when used as mucolytic
Drug interaction with other sulfur-containing compounds has theoretical risk of additive effects
May interact with drugs metabolized by hepatic conjugation pathways; clinical relevance varies
Potential to decrease bioavailability of antibiotics such as amoxicillin when taken simultaneously; staggering doses recommended
Interactions with vitamins and mineral supplements generally not clinically significant
Herbal supplements with antioxidant properties (e.g., Ginkgo biloba) may have additive effects
No known interaction reducing effectiveness of acetaminophen, but NAC is an antidote for its toxicity
Exposure to activated charcoal after overdose can complicate timing of NAC administration
Monitoring for drug interactions is essential during polypharmacy especially in chronic disease states

Preparations Of The Drug

NAC oral tablets, typically 600 mg per tablet for mucolytic and supplemental use
Oral sustained-release formulations (e.g., N-A-C Sustain) designed for once or twice daily dosing
Oral solutions or powders for reconstitution to liquid forms, concentrations vary by product
Intravenous solutions (e.g., Acetadote) formulated for rapid administration in acetaminophen overdose protocols
Nebulized inhalation preparations for respiratory applications to reduce mucus viscosity
Combination products with other antioxidants or vitamins used for dietary supplementation
Over-the-counter products marketed as nutritional supplements with varying NAC concentrations
Pharmaceutical grade sterile formulations for hospital use with strict storage requirements
Bulk powder forms used in compounding pharmacies for customized dosing
Sachets containing oral granules for easier administration in some regions
Intramuscular preparations are rare and uncommon in clinical use
Packaging designed to protect from moisture and light to maintain stability
Combination formulations with lysine or other agents for enhanced bioavailability
Available under multiple brand names varying by country and regulatory approval
Special pediatric formulations with tailored dosing concentrations and volumes